The U.S. Federal Trade Commission sues the World Professional Association for Transgender Health (WPATH), alleging the group’s materials and guidance on transgender medical treatments are unlawful. According to reports, WPATH publishes clinical guidance intended to inform how clinicians evaluate and treat transgender patients. The FTC action centers on how the association provides those recommendations and whether the group’s communications comply with federal consumer-protection rules.
The lawsuit comes as regulators and courts continue to address the role of medical organizations, credentialed expertise, and promotional communications in public-facing materials. It also reflects ongoing scrutiny over how health-related claims are presented to patients and the public. WPATH has not been summarized in the provided excerpts, but the case is framed by the FTC as a dispute over the legal treatment of advice that reaches consumers seeking health information.
The FTC seeks court relief in federal court, and the litigation is ongoing.
